The FDA has approved EchoPixel’s True3D Viewer which converts anatomical data to 3D virtual reality images.
The FDA has approved EchoPixel’s True3D Viewer, the first platform to convert anatomical data from patients into fully interactive, 3D virtual reality images, EchoPixel announced yesterday.
True3D compiles data from MRI, CT, and all DICOM imaging data to create an interactive holograph of patient-specific body parts, instead of flat 2D images, EchoPixel said in a release. The rendering allows physicians and students to interact with the anatomical structures. True3D’s technology is an effort to dramatically improve speed and efficacy across a broad range of medical operations, the release said.
“Since CT scans were invented in the 1970s, doctors have learned about patient anatomy by mentally piecing together multiple images on flat screens,” Ron Schilling, CEO of EchoPixel, said in the release. “That’s not what the inside of a patient looks like. When working with doctors, we found they were wasting energy trying to solve imaging problems instead of clinical ones. Using virtual reality, we can provide an interactive, three-dimensional view of patient data that is far clearer and more realistic.”
Early clinical trials have shown True3D technology to impact procedures in surgery and radiology, the release said. EchoPixel uses proprietary protocols to formulate and distribute expert-derived methodologies in step-by-step 3D format, according to the release.
[[{"type":"media","view_mode":"media_crop","fid":"33441","attributes":{"alt":"t3D Viewer","class":"media-image","id":"media_crop_6027850334752","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3525","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 209px; width: 400px;","title":"t3D Viewer","typeof":"foaf:Image"}}]]
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.